🧪
hypothesis

microglial inflammasome tone defines the therapeutic window for: How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegener

Hypothesis

microglial inflammasome tone defines the therapeutic window for: How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegener

The same signal may be beneficial early and damaging late.
🧬 microglial inflammasome tone🩺 neurodegeneration🎯 Composite 34%💱 $0.56▲3.7%active
EvidencePending (0%)📖 6 cit🗣 1 debates 6 support 1 oppose
✓ All Quality Gates Passed
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite34%

🧪 Overview

The same signal may be beneficial early and damaging late. Testing microglial inflammasome tone with dietary fiber challenge should reveal a disease-stage interaction and define when intervention is protective versus counterproductive.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Amyloid-beta/Tau<br/>Priming Signal"]
    B["Lysosomal Damage<br/>Cathepsin B Release"]
    C["NLRP3 Sensor<br/>NEK7 Binding"]
    D["ASC Speck Formation<br/>PYD Domain Oligomerization"]
    E["Pro-Caspase-1<br/>CARD Domain Recruitment"]
    F["Active Caspase-1<br/>Cleavage Activation"]
    G["IL-1B/IL-18 Secretion<br/>Pro-inflammatory"]
    H["Pyroptosis<br/>Gasdermin D Pore"]
    I["Feed-Forward Loop<br/>Sustained SASP Inflammasome"]
    A --> C
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    F --> H
    G --> I
    I -.->|"amplifies"| C
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style I fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports1 contradicts
Supports
Microglia Biology: One Century of Evolving Concepts.
Cell2019PMID:31585077medium
Supports
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
Transl Neurodegener2020PMID:33239064medium
Supports
Microglia in Alzheimer's disease.
J Cell Biol2018PMID:29196460medium
Supports
Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation.
Neuroscientist2019PMID:29931997medium
Supports
Microglia in multiple sclerosis: Protectors turn destroyers.
Neuron2022PMID:35882229medium
Contradicts
causal direction requires longitudinal perturbation
skeptic_round
📖 Linked Papers (12)Export BibTeX ↗
Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis.
Basic Res Cardiol (2025) · PubMed:40958035 ↗
No figures
Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis.
Nat Rev Rheumatol (2024) · PubMed:38600215 ↗
No figures
Microglia in multiple sclerosis: Protectors turn destroyers.
Neuron (2022) · PubMed:35882229 ↗
No figures
Microglia in multiple sclerosis: Protectors turn destroyers.
Neuron (2022) · PubMed:35882229 ↗
No figures
Pyroptosis in acute pancreatitis and its therapeutic regulation.
Apoptosis (2022) · PubMed:35687256 ↗
No figures
AIM2 in regulatory T cells restrains autoimmune diseases.
Nature (2021) · PubMed:33505023 ↗
No figures
AIM2 in regulatory T cells restrains autoimmune diseases.
Nature (2021) · PubMed:33505023 ↗
No figures
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
Translational neurodegeneration (2021) · PubMed:33239064 ↗
No figures
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
Translational neurodegeneration (2021) · PubMed:33239064 ↗
No figures
ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation.
Science (2018) · PubMed:30467171 ↗
No figures
Microglia in Alzheimer's disease.
The Journal of cell biology (2018) · PubMed:29196460 ↗
No figures
Microglia in Alzheimer's disease.
The Journal of cell biology (2017) · PubMed:29196460 ↗
No figures

🏥 Translation

🧬 3D Protein Structure — MICROGLIAL

No curated PDB or AlphaFold mapping for MICROGLIAL yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for microglial inflammasome tone →

No DepMap CRISPR Chronos data found for microglial inflammasome tone.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Falling
7d Momentum
▼ 1.2%
Volatility
High
0.1984
Events (7d)
3
Price History
▲3.7%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF inflammasome tone is the actionable state, THEN dysbiosis-induced cognitive impairment will track caspase-1-positive microglia with r >=0.35 across animals within 10 weeks.Caspase-1-positive microglial fraction correlates with memory deficit severity at r >=0.35.— no observation —pending0.57
IF microglial inflammasome tone defines the treatment window, THEN NLRP3 inhibition during early dysbiosis will reduce brain IL-1B by >=40%, but the same treatment after established neuronal injury wiEarly-treatment arm shows >=40% IL-1B reduction and late-treatment arm shows <15% reduction relative to matched controls.— no observation —pending0.59
🔮 Falsifiable Predictions (2)
pendingconf 59%
IF microglial inflammasome tone defines the treatment window, THEN NLRP3 inhibition during early dysbiosis will reduce brain IL-1B by >=40%, but the same treatment after established neuronal injury will reduce IL-1B by <15%.
Predicted outcome: Early-treatment arm shows >=40% IL-1B reduction and late-treatment arm shows <15% reduction relative to matched controls.
Falsification: Early and late NLRP3 inhibition have indistinguishable effects or both reduce IL-1B by >=40%.
pendingconf 57%
IF inflammasome tone is the actionable state, THEN dysbiosis-induced cognitive impairment will track caspase-1-positive microglia with r >=0.35 across animals within 10 weeks.
Predicted outcome: Caspase-1-positive microglial fraction correlates with memory deficit severity at r >=0.35.
Falsification: Correlation is |r| <0.10 or driven entirely by sickness/locomotor covariates.
View on SciDEX ↗